Mark Schumacher, MD, PhD
Director, PARC
Professor and Chief, Division of Pain Medicine
Anesthesia
+1 415 502-7022
Dr. Schumacher's research focuses on the identification of novel analgesic targets in the peripheral nervous system to treat chronic pain without risk of addiction. Currently, he is investigating a class of transcription inhibitors previously used to treat cancer that now show promise to block pain from inflammation and nerve injury.
Publications: